The market for legal marijuana continues to expand. Already, 33 states plus D.C. have legalized medicinal pot and 10 states have okayed recreational use, as has all of Canada. Mexico plans to follow.
In 2019, global revenue reached $17.7 billion. According to Grand View Research, it's expected to skyrocket to $73.6 billion by 2027. More dispensary outlets are being opened, more products are on sale, and sales are especially booming for pharmaceutical cannabis, an essential business.
More than ever, this is the time to get in on Zacks Marijuana Innovators.
This service applies the timely predictive power of the Zacks Rank to buy and sell decisions. From January 1, 1988 to July 6, 2020 this proven system has more than doubled the S&P 500. The average gain has been +24.3% per year.
Maybe +24.3% per year doesn't sound thrilling, but let's suppose you had invested $10,000 in the S&P 500 in 1988. Rebalancing monthly and not counting fees, you would have more than $260,000 today.
But if you had put that same $10,000 into the Zacks Rank system, it could have compounded to more than $11.9 million dollars.
With 20 years of trading experience, Dave Borun applies a macro approach based on global events and economic news. Then he uses Zacks' powerful research tools to find stocks that are likely to outperform their peers based on current conditions. He targets the few truly innovative growers, pharmaceutical companies, financial firms, and suppliers that offer investors double- and triple-digit growth potential.
Plus...That Same Dollar Brings You All Other Zacks Buys & Sells Through Zacks Ultimate
In other words, during your 30-day trial you can also sample:
No obligation beyond $1.
You may cancel at any time.
Just imagine what winners from celebrated Zacks experts can do for your portfolio.
Here are some of the top, recently closed position from our short-term trading portfolios¹:
And several recent examples from our long-term investing portfolios¹:
7 Best Stocks for the Next 30 Days
Taken from a proven list of 220 Zacks Rank #1 Strong Buys, this Special Report reveals 7 companies poised for immediate breakout. Each stock was selected because of its superior short-term profit potential under current market conditions.
5 Stocks Set to Double
In this Special Report five Zacks experts each recommend their single favorite stock predicted to increase +100% and more in the next 12 months. This is a must-read report for long-term investors.
5G: Top Stocks for the $12 Trillion Data Revolution
In this Special Report, Zacks experts explore a radical new technology set to change the world. The arrival of 5G has been called "the 4th Industrial Revolution" - and 3 breakthrough stocks could deliver potentially huge returns for early investors.
Century of Biology: 7 Biotech Stocks to Buy Right Now
Get Zacks's top 7 stocks to ride the $775 billion biotech revolution. Each of these picks could generate explosive gains in the coming months.
Early Warning Alert: Stocks to Sell Before They Report Earnings in the Coming Week
This Special Report reveals stocks that our system predicts will report the worst NEGATIVE earnings surprises from July 20 - 24. If any of these tickers are among your holdings, consider getting rid of them now.
COVID-19 Investor's Guide: 5 Stocks to Profit from the "New Normal"
Get Zacks' top 5 stocks poised to profit from the changes unleashed by the Coronavirus outbreak. Each of these picks provides critical high-tech solutions and could generate explosive gains in the coming months.
Zacks Ultimate Four
These aren't just four promising stocks. They were hand-picked by Zacks experts to offer the greatest upside potential over the next quarter.
Investing For Impact: Zacks' 4 Hottest ESG Buys
Get Zacks' 4 hottest recommendations poised to profit from the skyrocketing demand for stocks focused on responsible, sustainable business practices. Each of these picks provides exceptional profit potential, decreased volatility. They could be among the most profitable stocks in your portfolio in 2020 and beyond.
Valued at $99, it is yours free when you start your 30-day trial.
Important: To maximize the benefits of this service, we must limit the number of members who have access to its quick-reaction buys and sells. The portfolio closes to new investors midnight Sunday.
Questions? Call toll-free at 1.888.775.8348 M-F, 10 am - 6 pm ET. Outside the U.S., 1.312.265.9309.
What happens after my 30-day Zacks Ultimate trial is over?
You'll be notified at least seven days before your trial ends. You can choose to:
Are there money-back guarantees?
You are backed with two assurances. The first is a Guarantee of Satisfaction. You may cancel up to 90 days after your $1 trial is over and if the service has not exceeded your expectations, then your money will be refunded - including the $1 you paid for the trial.
You will also be protected by a full-year, money-back Performance Guarantee. Details. That means if we don't help you beat the market, we'll refund your subscription.
What portfolios are included in Zacks Ultimate?
You gain real-time access to buys, sells, and market commentary from all of these private services:
Will following all Zacks portfolio recommendations be hard work or "too much information?"
Not at all - most members start by quickly scanning each of the portfolios, and then simply narrow them down to the one(s) that suit them best.
Also, each day you receive a summary email that spotlights intraday trades and key market commentary from the various services.
And if you have any questions or need any help sorting out which portfolios are best for you, just pick up the phone and talk to a real person who can give you the info you need.
Since 2011, tens of thousands have taken advantage of this 30-day see-all experience. Don't miss this opportunity to discover the impact that the Zacks Rank can have on your portfolio.
It only costs $1. And not 1 cent of further obligation.
Marijuana Innovators is presently closed to new members, but new spots will become available soon.
Get on the waiting list now, and we'll contact you when a spot opens up.
No obligation, of course.*All fields required